The Partnership for Quality Medical Donations is a unique alliance of Non-Profit and  Corporate organizations committed to bringing measurable health impact to under-served and vulnerable people through active engagement with global partners and local communities.

STATEMENT OF VISION:  By assuring excellence in medical product donations and service delivery,
geography and economic status are no longer barriers to everyone living a healthier life.

STATEMENT OF MISSION:  PQMD is a global alliance leading the development and championing
of high standards in medical supply and service donation.  PQMD seeks to enhance access to
health care in underserved communities and in areas affected by disaster.

Washington AIDS project uses home visits, pop-up clinics to get HIV patients back into care with Foundation support 

If HIV-positive patients in the greater Washington, D.C., area cannot get to their treatment, the treatment will come to them.

That’s the focus of an innovative, community-driven pilot program – funded in part by the Bristol-Myers Squibb Foundation – that is using a combination of home visits and pop-up clinics co-located with community partners such as churches and housing developments in targeted neighborhoods to help 600 HIV-positive patients return to HIV care.

International Medical Corps Calls on Yemen's Warring Parties to Enable Relief Agencies to Assist Civilians Trapped in the Violence 

 September 1, 2015

LOS ANGELES, CA – Amid escalating fighting for control of Yemen’s third largest city of Taiz, International Medical Corps is calling on the warring parties to provide relief agencies the humanitarian space needed to get emergency aid to civilians trapped in the violence.

“Our courageous colleagues in Taiz, who through five months of conflict have continuously delivered lifesaving assistance to residents of the city and surrounding areas, are now unable to do their work,” said Chris Skopec, International Medical Corps’ Senior Director for Emergency Preparedness and Response. “Our office in the city has taken direct hits, our team there can move only at great personal risk and our emergency relief supplies are inaccessible.

Baxter Sustainability Report Highlights Success in 2014


Baxter's 2014 Sustainability Report, available at baxter.com/sustainability-report, highlights the significant progress towards 2015 goals, and recent actions taken by the company that align with its nine sustainability priorities, which include strengthening access to healthcare, creating an inclusive workplace and enhancing math and science education. Priorities also include a range of environmental initiatives such as reducing greenhouse gas emissions, waste generation, and water use. Baxter's Sustainability Report is aligned with the Global Reporting Initiative G3 Guidelines, which provide a uniform and transparent set of metrics to systematically report on sustainability initiatives and results.

"Baxter's accomplishments and aspirations as a corporate citizen depend on our sustainability as a business," said Robert L. Parkinson, Jr., Baxter's chairman and chief executive officer. "As a healthcare industry leader, we must constantly advance and innovate to create lasting social, environmental and economic value for the communities we serve worldwide."

Haiti Refugee Crisis


Since mid-June 2015, Heart to Heart International (HHI) has been responding to the crisis at the border between Haiti and the Dominican Republic, providing medical care, food and aid for more than one thousand refugees.  These men, women and children have filled makeshift camps, fleeing the political winds in the Dominican Republic and the possibility of government sanctioned deportations.  

 The numbers vary, but as of this writing, approximately 40,000 people have either left on their own or were forced to cross the border into Haiti.  And approximately 1,100 of these refugees sought shelter and aid in a region where Heart to Heart International normally operates – Southeast Haiti.  This is the same region of Haiti where HHI runs mobile health clinics and works with partners like BD to train village healthcare workers.

Merck in the News - Global Collaboration Enabled Vaccine to Move
from First-in-Human Studies to Initial Phase 3 Results Within One Year


Merck (known as MSD outside the US and Canada) said today that its investigational Ebola vaccine candidate, rVSV-ZEBOV, was found to have 100 percent efficacy in an analysis of interim data from a Phase 3 ring vaccination trial in Guinea. Preliminary conclusions from this study, which is continuing, were published on-line today in The Lancet

The authors report that vaccine efficacy was 100 percent (95% confidence interval: 74.7 - 100%; p=0.0036) following vaccination with a single dose of the rVSV-ZEBOV vaccine. It appeared that all vaccinated individuals were protected against Ebola virus infection within 6 to 10 days of vaccination.

To date, more than 4,000 participants have received the vaccine in this innovative trial, called “Ebola ça suffit” or “Ebola, that’s enough.” The trial was conducted by a team that included researchers from the World Health Organization (WHO), the Norwegian Institute of Public Health, the Health Ministry of Guinea and Médecins sans Frontières, among others. The results from this continuing study, as well as other studies already underway (see below) and additional studies to be conducted, will be used to support worldwide regulatory submissions.

GSK Announces Malaria Candidate Vaccine

GSK announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for its malaria candidate vaccine MosquirixTM, also known as RTS,S, in children aged 6 weeks to 17 months. Following this decision, the World Health Organization (WHO) will now formulate a policy recommendation on use of the vaccine in national immunisation programmes once approved by national regulatory authorities.

<< first < Prev 1 2 3 4 Next > last >>

Page 1 of 4
powered by MemberClicks